Publications

Highlights

Genome-Wide Reduction in Chromatin Accessibility and Unique Transcription Factor Footprints in Endothelial Cells and Fibroblasts in Scleroderma Skin
Tsou PS, Palisoc PJ, Ali M, Khanna D, Sawalha AH. Arthritis & Rheumatology. February 14, 2021

Tocilizumab Prevents Progression of Early Systemic Sclerosis Associated Interstitial Lung Disease
Roofeh D, Lin CJF, Goldin J, Kim GH, Furst DE, Denton CP, Huang S, Khanna D; focuSSced investigators. Arthritis & Rheumatology. February 3, 2021

How Do Patients Define Raynaud’s Phenomenon? Differences Between Primary and Secondary Disease
Murphy SL, Lescoat A, Alore M, Hughes M, Pauling J, Sabbagh M, Khanna D. Clinical Rheumatology. January 24, 2021

Targeting CD38-Dependent NAD+ Metabolism to Mitigate Multiple Organ Fibrosis
Shi B, Wang W, Korman B, Kai L, Wang Q, Wei J, Bale S, Marangoni RG, Bhattacharyya S, Miller S, Xu D, Akbarpour M, Cheresh P, Proccissi D, Gursel D, Espindola-Netto JM, Chini CCS, de Oliveira GC, Gudjonsson JE, Chini EN, Varga J. iScience. January 22, 2021

UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 Reflux Scale Correlates with Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis
Abignano G, Mennillo GA, Lettieri G, Temiz Karadag D, Carriero A, Padula AA, Del Galdo F, Khanna D, D'Angelo S. The Journal of Rheumatology. January 15 2021

Lymphocyte Subset Abnormalities in Early Diffuse Cutaneous Systemic Sclerosis
Fox DA, Lundy SK, Whitfield ML, Berrocal V, Campbell P, Rasmussen S, Ohara R, Stinson A, Gurrea-Rubio M, Wiewiora E, Spino C, Bush E, Furst D, Pillai S, Khanna D. Arthritis Research & Therapy. January 6, 2021

Development of a Musculoskeletal Ultrasound Protocol to Examine Upper Extremity Rehabilitation Outcomes in Systemic Sclerosis
Murphy SL, Krause D, Roll SC, Gandikota G, Barber M, Khanna D. Journal of Diagnostic Medical Sonography. November 22, 2020

Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations with Skin/Lung Fibrosis
Bellocchi C, Ying J, Goldmuntz EA, Keyes-Elstein L, Varga J, Hinchcliff ME, Lyons MA, McSweeney P, Furst DE, Nash R, Crofford LJ, Welch B, Goldin JG, Pinckney A, Mayes MD, Sullivan KM, Assassi S. Arthritis & Rheumatology. November 1, 2020

Fatigue Predicts Future Reduced Social Participation, Not Reduced Physical Function or Quality of Life in People with Systemic Sclerosis
Murphy SL, Whibley D, Kratz AL, Poole JL, Khanna D. Journal of Scleroderma and Related Disorders. October 18, 2020

Considerations for a Combined Index for Limited Cutaneous Systemic Sclerosis to Support Drug Development and Improve Outcomes
Lescoat A, Murphy SL, Roofeh D, Pauling J, Hughes M, Sandler R, Zimmermann F, Wessel R, Townsend W, Chung L, Denton CP, Merkel PA, Steen V, Allanore Y, Del Galdo F, Godard D, Cella D, Farrington S, Buch MH, Khanna D. Journal of Scleroderma and Related Disorders. October 5, 2020

Dissecting the Cellular Mechanism of Prostacyclin Analog Iloprost in Reversing Vascular Dysfunction in Scleroderma
Tsou PS, Palisoc PJ, Flavahan NA, Khanna D. Arthritis & Rheumatology. October 1, 2020

Emerging Drugs for the Treatment of Scleroderma: A Review of Recent Phase 2 and 3 Trials
Roofeh D, Lescoat A, Khanna D. Expert Opinion on Emerging Drugs. September 3, 2020

Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis
Nagaraja V, Matucci-Cerinic M, Furst DE, Kuwana M, Allanore Y, Denton CP, Raghu G, Mclaughlin V, Rao PS, Seibold JR, Pauling JD, Whitfield ML, Khanna D. Arthritis & Rheumatology. March 5, 2020

Cytotoxic CD4+ T Lymphocytes May Induce Endothelial Cell Apoptosis in Systemic Sclerosis
Maehara T, Kaneko N, Perugino CA, Mattoo H, Kers J, Allard-Chamard H, Mahajan VS, Liu H, Murphy SJ, Ghebremichael M, Fox D, Payne AS, Lafyatis R, Stone JH, Khanna D, Pillai S. The Journal of Clinical Investigation. January 28, 2020

Faculty Publications

Learn More